Prostate Cancer · Published 2025-01-01 · DOI 10.1155/proc/8842203
Conclusion: Our study suggests that SESN2 inhibits prostate cancer cells by inducing autophagy through the AMPK/mTOR signaling pathway. These results indicate that SESN2 might be a novel target for prostate cancer.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →